| | Cancer | Other Cancers

Cancer Prognosis: Factors Influencing Survival and the Impact of Early Detection

Stage & Type Are Paramount

Stage I (localized): Often curable with surgery ± adjuvant therapy. 5-yr survival >90% for many cancers (breast, prostate, melanoma, thyroid).
Stage IV (metastatic): Generally incurable; treatment goals shift to prolongation, palliation. 5-yr survival varies: breast ~30%, lung ~8%, pancreatic ~3%.

Historical Survival Trends

1975–1977: Overall 5-yr survival ~50%.
2008–2014: Overall 5-yr survival ~68% (SEER data).
Gains driven by screening (breast, cervical, colorectal), targeted therapies, immunotherapy, supportive care.

Individual Prognostic Factors

Treatment Influence

Surgery ± radiation = potentially curative for localized disease.
Systemic therapy (chemo, targeted, immune) improves survival in adjuvant & metastatic settings.
Clinical trials offer access to novel agents.

Hope & Progress

Many patients achieve long-term remission or cure. Survivorship care plans address late effects, surveillance, and quality of life. Early detection remains the single most powerful lever for improving outcomes.

Other Cancers - Related Articles

Factor	Impact
Age	Younger → better tolerance, but some cancers more aggressive
Performance status (ECOG/Karnofsky)	Strong predictor of treatment tolerance & survival
Comorbidities	Charlson index; limits aggressive therapy
Molecular markers	e.g., ER/PR/HER2 (breast), EGFR/ALK (lung), MSI (colorectal)
Treatment access & adherence	Disparities by race, geography, insurance